Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
Mark J. Millan, Guy M. Goodwin, Andreas Meyer‐Lindenberg, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 5, pp. 599-656
Closed Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Altering the course of schizophrenia: progress and perspectives
Mark J. Millan, Annie Andrieux, George Bartzokis, et al.
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 7, pp. 485-515
Closed Access | Times Cited: 466
Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
Brisa Solé, Esther Jiménez, Carla Torrent, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 8, pp. 670-680
Open Access | Times Cited: 243
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
The erring brain: Error‐related negativity as an endophenotype for OCD—A review and meta‐analysis
Anja Riesel
Psychophysiology (2019) Vol. 56, Iss. 4
Closed Access | Times Cited: 160
Drug repurposing: a systematic review on root causes, barriers and facilitators
Nithya Krishnamurthy, Alyssa Grimshaw, Sydney A. Axson, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 134
Single-cell transcriptomic evidence for dense intracortical neuropeptide networks
Stephen J Smith, Uygar Sümbül, Lucas T. Graybuck, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 142
Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
Kelly A. Berg, William P. Clarke
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 10, pp. 962-977
Open Access | Times Cited: 136
Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease
Nicola Simola, Sylvie Granon
Neuropharmacology (2018) Vol. 159, pp. 107420-107420
Closed Access | Times Cited: 135
Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
Tomas Hökfelt, Swapnali Barde, Qing Xu, et al.
Frontiers in Neural Circuits (2018) Vol. 12
Open Access | Times Cited: 124
Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
Philippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J. Millan
Progress in Neurobiology (2016) Vol. 151, pp. 57-100
Closed Access | Times Cited: 111
The role of the habenula in the transition from reward to misery in substance use and mood disorders
Albert Batalla, Judith R. Homberg, Tatiana V. Lipina, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 80, pp. 276-285
Open Access | Times Cited: 100
Animals, anxiety, and anxiety disorders: How to measure anxiety in rodents and why
Jaanus Harro
Behavioural Brain Research (2017) Vol. 352, pp. 81-93
Closed Access | Times Cited: 100
A review of the role of serotonin system genes in obsessive-compulsive disorder
Vanessa M. Sinopoli, Christie L. Burton, Sefi Kronenberg, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 80, pp. 372-381
Closed Access | Times Cited: 98
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Sara Costi, Laurel S. Morris, Katherine Kirkwood, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 5, pp. 437-446
Open Access | Times Cited: 56
Advances in transcranial focused ultrasound neuromodulation for mental disorders
Yu Shi, Wen Wu
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111244-111244
Closed Access | Times Cited: 1
From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care
Masaru Tanaka
Biomedicines (2025) Vol. 13, Iss. 1, pp. 167-167
Open Access | Times Cited: 1
An integrative review of methylation at the serotonin transporter gene and its dialogue with environmental risk factors, psychopathology and 5-HTTLPR
Helena Palma‐Gudiel, Lourdes Fañanás
Neuroscience & Biobehavioral Reviews (2016) Vol. 72, pp. 190-209
Closed Access | Times Cited: 71
New drug candidates for depression – a nationwide population‐based study
Lars Vedel Kessing, Helene C. W. Rytgaard, Thomas A. Gerds, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 139, Iss. 1, pp. 68-77
Open Access | Times Cited: 67
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
Aaron Tan, Sara Costi, Laurel S. Morris, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 6, pp. 1323-1333
Open Access | Times Cited: 66
Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia—New Developments and Future Perspective
Madeleine Monique Uys, Mohammed Shahid, Brian H. Harvey
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 62
Synaptic deficits in iPSC-derived cortical interneurons in schizophrenia are mediated by NLGN2 and rescued by N-acetylcysteine
Annie Kathuria, Kara Lopez-Lengowski, Bradley Watmuff, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 61
Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
Shun Zhu, Fang Liu, Ruiyuan Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
A review of resting-state fMRI correlations with executive functions and social cognition in bipolar disorder
Yara Massalha, Eleonora Maggioni, Antonio Callari, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 337-351
Closed Access | Times Cited: 19
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
Giuseppe Di Giovanni, Dubravka Švob Štrac, Montse Solé, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 58
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
Filippo Caraci, Francesca Calabrese, Raffaella Molteni, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 475-504
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top